RIO DE JANEIRO, BRAZIL – The Argentine Ministry of Health reported on Tuesday, August 10, 12,412 new coronavirus cases, bringing the total number of positives to 5,041,487. At the same time, deaths rose to 108,165 after 206 deaths were reported in the last 24 hours.
Argentina registered a daily record number of cases on May 27, when 41,080 cases were reported, while the highest number of deaths in a single day was verified on June 22, with 792 deaths.
In the province of Buenos Aires, 3,071 cases were reported on Tuesday; in the central province of Cordoba, 2,146 positive cases were registered; in Santa Fe (center), 963 were reported; and in the capital of the country, 466 cases were reported.
According to the official report, 4.69 million patients have already been discharged. The number of people with a confirmed diagnosis of Covid-19 who remain in intensive care units was 3,652, down from 7,969 on June 14.
The percentage of bed occupancy in intensive care units (ICU) for all types of pathologies is 51.6% at the national level and 49.8% if only Buenos Aires and its periphery are considered.
So far, 20.30 million tests for the virus have been carried out in the South American country, of which 102,072 were performed this Tuesday.
Argentina experienced an accelerated increase in Covid-19 cases in April and May, with a high level of occupancy of beds in intensive care units. However, the upward curve of positives began to ease in June after the imposition of new sanitary restrictions.
While seeking to leave behind the second wave of covid-19, Argentina, with some 45 million inhabitants, continues with its vaccination campaign against the coronavirus, which began at the end of last December, hoping to complete the inoculation scheme in August as many people as possible.
According to official data released today, 34.99 million doses have been applied so far. A total of 26.20 million people received the first dose of the vaccine, while 8.7 million people have already been inoculated with the second dose.
Argentina started to combine vaccines from different laboratories due to delays in the arrival of vaccines with the second component of Sputnik V, which for the time being, will be substituted with those developed by Moderna and AstraZeneca.
Last Monday, the country received 400,000 doses of Sputnik V component 2 in a flight from Moscow, and 500 liters of the antigen for local production by Richmond Laboratories are expected to arrive during the week.